BIOEXTRAX AB (85X0) — Financial Flexibility Index

Latest as of March 2026: 3.65x

BIOEXTRAX AB (85X0) has a Financial Flexibility Index of 3.65x as of March 2026. Free cash flow of €7.72 Million (operating CF €7.68 Million minus capex €46.00K) represents 4% of total liabilities (€2.11 Million). For the full cash flow conversion analysis, see cash flow conversion of BIOEXTRAX AB.

Financial Flexibility Index

3.65x
Free Cash Flow / Total Liabilities

Free Cash Flow

€7.72 Million
Operating CF − Capex

Total Liabilities

€2.11 Million
EUR

Capital Expenditures

€46.00K
EUR

BIOEXTRAX AB Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for BIOEXTRAX AB across 5 annual periods. Check 85X0 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Financial Flexibility Index for BIOEXTRAX AB (2021–2025)

Year-by-year free cash flow to debt coverage for BIOEXTRAX AB. Check 85X0 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 -7.37x €-25.89 Million €-26.05 Million €3.51 Million ▼ -16.6%
2024 -6.32x €-18.56 Million €-18.78 Million €2.94 Million ▲ +43.7%
2023 -11.22x €-22.21 Million €-23.31 Million €1.98 Million ▼ -537.4%
2022 -1.76x €-10.83 Million €-17.60 Million €6.15 Million ▼ -20.7%
2021 -1.46x €-7.50 Million €-8.48 Million €5.14 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities